Garenoxacin is a fluoroquinolone antibiotic used for the treatment of various bacterial respiratory tract infections, including sinusitis, pharyngitis, bronchitis, and pneumonia. By inhibiting the enzymes… Read more
Garenoxacin is a fluoroquinolone antibiotic used for the treatment of various bacterial respiratory tract infections, including sinusitis, pharyngitis, bronchitis, and pneumonia. By inhibiting the enzymes DNA gyrase and topoisomerase IV, this compound effectively prevents bacterial replication. This category features high-quality Garenoxacin reference standards, along with stable isotope-labelled compounds such as Garenoxacin-d4, which serve as essential tools for pharmaceutical analysis. Analytical laboratories utilize these materials for rigorous quality control, impurity profiling, and method validation during drug development. Incorporating stable isotope-labelled standards allows for precise quantification and accurate identification of metabolites or degradation products in complex biological matrices. These reference materials are critical for ensuring compliance with pharmacopeial standards and maintaining the consistency and safety of pharmaceutical products throughout the testing lifecycle.